Colorectal Cancer
Clinical Trials

1) Phase 1B single agent cohort part of Mirati 849-001/USO 19151: Cohort F – A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation CRC with KRAS G12C mutation – 21 SLOTS AVAILABLE! USOR will NOT participate in the cohort sub-studies nor the fed state (food effect) cohort.

Send UsA Message

    Call Now Button